Datagov Opendata Platform

The National Health Insurance Administration aims to enhance the quality of medical care for patients with myocardial infarction by selecting evidence-based medical indicator items for public disclosure, as a reference for medical treatment and healthcare quality for related diseases. The disclosed items are divided into three categories according to the treatment period and quality aspects, including inpatient process evaluation, evaluation of continued medication after discharge, and outcome evaluation. This includes the ratio of inpatients with acute myocardial infarction (AMI) undergoing LDL cholesterol testing during hospitalization, medication ratios for AMI patients during hospitalization and within three, six, and nine months after discharge, emergency department revisit ratios within three days of discharge for the same primary diagnosis or related condition, and unplanned readmission ratios within fourteen days of discharge for the same primary diagnosis or related condition.